Related Experiment Video
Updated: Aug 19, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001
Maria-Graciela Hollm-Delgado1, Robert Allard, Pierre A Pilon
1Direction de Santé Publique, Montréal, Québec, Canada.
Abstract:
We identified 306 invasive group A streptococcal infections (IGASI) by passive population-based surveillance in Montreal, Canada, from 1995 to 2001. The average yearly reported incidence was 2.4 per 100,000 persons, with a 14% death rate. Among clinical manifestations, incidence of pneumonia increased from 0.06 per 100,000 in 1995 to 0.50 per 100,000 in 2000. Over a span of 7 years, the odds of developing pneumonia increased (odds ratio [OR] = 1.21, 95% confidence interval [CI] 1.0-1.5), while they decreased for soft-tissue infections (OR = 0.86, 95% CI 0.7-1.0). Serotypes M1 and M3 accounted for 30% of IGASI. However, neither serotype was significantly associated with specific clinical manifestations, which suggests that manifestation development among IGASI might be attributable to host or environmental factors rather than the pathogen. In our study, these factors included age, gender, underlying medical conditions, and living environment, yet none explained temporal changes in risk for pneumonia and soft-tissue infections.
Insights
Invasive group A streptococcal infections (IGASI) showed a rising risk of pneumonia but a falling risk of soft-tissue infections between 1995-2001. Host and environmental factors, not specific M1/M3 serotypes, likely influenced these clinical changes.
Area of Science:
- Infectious Diseases
- Epidemiology
- Microbiology
Background:
- Invasive group A streptococcal infections (IGASI) pose a significant public health concern.
- Understanding temporal trends and clinical manifestations of IGASI is crucial for effective public health strategies.
- Previous research has not fully elucidated the factors driving changes in IGASI clinical presentations.
Purpose of the Study:
- To analyze the incidence and clinical manifestations of IGASI in Montreal from 1995 to 2001.
- To investigate temporal trends in the occurrence of pneumonia and soft-tissue infections associated with IGASI.
- To explore the role of specific serotypes and host/environmental factors in IGASI clinical outcomes.
Main Methods:
- Passive population-based surveillance was employed to identify IGASI cases.
- Data on clinical manifestations, serotypes, patient demographics, and underlying conditions were collected.
- Statistical analyses, including odds ratios and confidence intervals, were used to assess temporal trends and associations.
Main Results:
- A total of 306 IGASI cases were identified, with an average annual incidence of 2.4 per 100,000 persons and a 14% mortality rate.
- The incidence of pneumonia among IGASI cases significantly increased from 0.06 to 0.50 per 100,000 between 1995 and 2000 (OR=1.21).
- Conversely, the odds of soft-tissue infections decreased (OR=0.86), while serotypes M1 and M3, though common, were not linked to specific manifestations.
Conclusions:
- Temporal shifts in IGASI clinical patterns, specifically an increase in pneumonia and decrease in soft-tissue infections, were observed.
- The development of specific clinical manifestations appears to be influenced more by host and environmental factors than by the infecting serotype.
- Further research is needed to identify the specific host and environmental factors contributing to these observed temporal changes in IGASI.
Related Concept Videos
Staphylococcal Skin Infections
Streptococcal Pharyngitis
Clinical Significance of Antibiotic Resistance
Determinants of Bacterial Pathogenicity and Virulence
Rheumatic Heart Disease I: Introduction
Bacterial Meningitis I: Introduction